MvVO Art Launches AD ART SHOW

Treatment of prostate cancer in German hospitals

Treatment of prostate cancer in German hospitals


Statistics of the World Health Organization demonstrates that prostate cancer is the most common type of oncology in European men. Initiated timely, therapy of the early disease stages leads to almost 100% 5-year survival rate.


Statistics of the World Health Organization demonstrates that prostate cancer is the most common type of oncology in European men. Initiated timely, therapy of the early disease stages leads to almost 100% 5-year survival rate. Unfortunately, used widely PSA blood test cannot guarantee early cancer detection in all cases. That is why more accurate tests Progensa, phi, and 4Kscore are applied in Germany. Conventional prostate cancer treatment in Germany is supplemented with Lutetium-177 and Actinium-225 PSMA therapy, robotic surgical techniques, and immunotherapeutic methods.

The most informative diagnostic procedures

In the most beneficial prognostically case, the disease is revealed during the screening examination with a prostate-specific antigen blood test or a digital rectal examination (DRE). These are the most easy-to-perform and cost-effective procedures.

DRE is a direct manual palpation of the prostate gland via the rectum. The procedure does not require any equipment, just a pair of medical gloves.

The PSA blood test may be indicative of the prostate cancer in men without any complaints. If the PSA level exceeds 10, chance of having prostate malignancy is over 50%. Men with high PSA level require further tests, including:

  • Transrectal ultrasonography (TRUSG). Ultrasound helps to assess size of the prostatic gland and presence of neoplasms or suspicious foci inside it.
  • Biopsy from up to 12 loci. This is a “gold standard” in the cancer diagnostics. Harvested prostatic tissue is investigated with the help of microscope; immunohistochemical tests can also be performed.
  • Tomography (MRI, CT scan, PSMA-PET CT) gives more detailed data on state of the prostate and neighboring organs, detects cancer metastasizing.
  • Osteoscintigraphy is the specialized examination that reveals bone metastases.

Determining stage of prostate cancer

Depending on the examination results, the following stages of prostate cancer are distinguished:

  • Stage I includes neoplasms that have not grown outside the prostatic gland. Typically, they increase in size slowly and may never cause any complaints. Treatment of elderly patients with stage I cancer may be limited to active surveillance or observation.
  • Stage II tumors are larger in size but still do not spread beyond the prostatic capsule. They are often accompanied by higher PSA levels. At this stage, spectrum of treatments varies from observation to radical prostatectomy with the subsequent irradiation.
  • Stage III neoplasms grow outside the prostate and may affect the bladder or rectum. Distant organs and lymph nodes are not involved. Treatment options at this stage include radiation therapy and prostatectomy (in eligible patients).
  • Stage IV tumors spread to nearby lymph nodes, distant organs and bones. Goals of treatment at this stage include controlling growth of the tumor and improving quality of life.

Conventional and novel treatment options

In Germany, doctors choose between conventional therapies, medical innovations and own developments:

  1. Surgery, including prostatectomy and resection of the gland. Surgery may be performed with the help of precise robotic system.
  2. Radiation therapy with application of therapeutic radionuclides Actinium-225 or Lutetium-177, and radioactive seeds implantation (interstitial brachytherapy).
  3. Chemotherapy with cabazitaxel or docetaxel combined with prednisone. This regimen is efficient in men with metastatic cancer that is resistant to the hormone therapy.
  4. Immunotherapy with vaccine Sipuleucel-T (Provenge). It is applied as a part of advanced prostate cancer treatment scheme.
  5. Androgen deprivation therapy with enzalutamide blocks prostate stimulation with male hormones and prevents tumor growth and spreading.
  6. Symptomatic therapy, including painkillers.
  7. Bone-modifying drugs in men with bone metastases.

Booking Health makes treatment abroad easy

Planning treatment of prostate cancer in Germany, a patient should start from choosing the healthcare facility considering its independent statistics, availability of the equipment and qualified healthcare professionals.

For the patients and their relatives with little or no relevant experience it will be more convenient to contact Booking Health. Medical tourism provider Booking Health assists people from 75 countries in undergoing prostate cancer treatment in Germany. Booking Health offers:

  • Making an informed choice between German hospitals, doctors and treatment options.
  • Booking an appointment for outpatient or inpatient treatment.
  • Assisting in visa issuing and preparing medical documents.
  • Translation of the previous medical reports.
  • Monitoring of all procedures by independent experts.
  • Communication with clinic and doctor after the program completion.
  • Financial control, avoiding overpricing (saving up to 50%).
  • Booking tickets and accommodation, services of interpreter, transfer organization.
  • Comprehensive support that allows you to concentrate at your health restoring.


More in Health

Ikaria Lean Belly Juice Reviews – Fake Ikaria Juice or Real Customer Results?

WriterJune 23, 2022

What’s The Difference Between Prescription Discount Plans And Prescription Drug Insurance?

WriterJune 23, 2022

How Lifestyle Changes Can Help Manage Psoriasis Symptoms

WriterJune 22, 2022

Food to Eat For Essential Bone-Building Nutrients

WriterJune 17, 2022

Dangers Of Using Prescription Drugs: Addiction, Overdose and More

WriterJune 16, 2022

3 Practical Ways to Handle Insomnia

WriterJune 9, 2022

How to Stay Healthy While Working at Home

WriterJune 6, 2022

Why do People Seek Complementary Massage Therapies for Overall Wellness?

WriterMay 31, 2022

Alcohol-Related Deaths in the UK on the Rise

WriterMay 31, 2022